39 related articles for article (PubMed ID: 22542933)
1. Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35®.
Nivoliez A; Camares O; Paquet-Gachinat M; Bornes S; Forestier C; Veisseire P
J Biotechnol; 2012 Aug; 160(3-4):236-41. PubMed ID: 22542933
[TBL] [Abstract][Full Text] [Related]
2. Elemental sulfur enhances the anti-fungal effect of Lacticaseibacillus rhamnosus Lcr35.
Kaur M; Miquel S; Ollivier-Nakusi L; Thoral C; Vareille-Delarbre M; Bekirian C; d'Enfert C; Fontaine T; Roget K; Forestier C
Microbes Infect; 2024; 26(3):105286. PubMed ID: 38160785
[TBL] [Abstract][Full Text] [Related]
3. Study of the Lactobacillus rhamnosus Lcr35® properties after compression and proposition of a model to predict tablet stability.
Muller C; Mazel V; Dausset C; Busignies V; Bornes S; Nivoliez A; Tchoreloff P
Eur J Pharm Biopharm; 2014 Nov; 88(3):787-94. PubMed ID: 25128853
[TBL] [Abstract][Full Text] [Related]
4. Unlocking the Potential of Probiotics: A Comprehensive Review on Research, Production, and Regulation of Probiotics.
da Silva TF; Glória RA; Americo MF; Freitas ADS; de Jesus LCL; Barroso FAL; Laguna JG; Coelho-Rocha ND; Tavares LM; le Loir Y; Jan G; Guédon É; Azevedo VAC
Probiotics Antimicrob Proteins; 2024 Mar; ():. PubMed ID: 38539008
[TBL] [Abstract][Full Text] [Related]
5.
Poupet C; Rifa É; Theil S; Bonnet M; Veisseire P; Cardin G; Guéret É; Rialle S; Chassard C; Nivoliez A; Bornes S
Front Microbiol; 2022; 13():1062113. PubMed ID: 36620055
[TBL] [Abstract][Full Text] [Related]
6. Sheep Milk Symbiotic Ice Cream: Effect of Inulin and Apple Fiber on the Survival of Five Probiotic Bacterial Strains during Simulated In Vitro Digestion Conditions.
Kowalczyk M; Znamirowska-Piotrowska A; Buniowska-Olejnik M; Pawlos M
Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364717
[TBL] [Abstract][Full Text] [Related]
7. Distribution of Genes Related to Probiotic Effects Across Lacticaseibacillus rhamnosus Revealed by Population Structure.
Dutra-Silva L; Matteoli FP; Arisi ACM
Probiotics Antimicrob Proteins; 2023 Jun; 15(3):548-557. PubMed ID: 34699013
[TBL] [Abstract][Full Text] [Related]
8. Entering First-in-Human Clinical Study With a Single-Strain Live Biotherapeutic Product: Input and Feedback Gained From the EMA and the FDA.
Paquet JC; Claus SP; Cordaillat-Simmons M; Mazier W; Rawadi G; Rinaldi L; Elustondo F; Rouanet A
Front Med (Lausanne); 2021; 8():716266. PubMed ID: 34458291
[TBL] [Abstract][Full Text] [Related]
9. Insights on the Critical Parameters Affecting the Probiotic Viability During Stabilization Process and Formulation Development.
Gurram S; Jha DK; Shah DS; Kshirsagar MM; Amin PD
AAPS PharmSciTech; 2021 May; 22(5):156. PubMed ID: 34008083
[TBL] [Abstract][Full Text] [Related]
10.
Poupet C; Chassard C; Nivoliez A; Bornes S
Front Nutr; 2020; 7():135. PubMed ID: 33425969
[No Abstract] [Full Text] [Related]
11. Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35.
Dausset C; Bornes S; Miquel S; Kondjoyan N; Angenieux M; Nakusi L; Veisseire P; Alaterre E; Bermúdez-Humarán LG; Langella P; Engel E; Forestier C; Nivoliez A
Sci Rep; 2020 Oct; 10(1):17074. PubMed ID: 33051479
[TBL] [Abstract][Full Text] [Related]
12. Investigation into In Vitro and In Vivo
Veisseire P; Bonnet M; Saraoui T; Poupet C; Camarès O; Gachinat M; Callon C; Febvre G; Chassard C; Bornes S
Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32570901
[TBL] [Abstract][Full Text] [Related]
13. Development of Probiotic Formulations for Oral Candidiasis Prevention: Gellan Gum as a Carrier To Deliver Lactobacillus paracasei 28.4.
Ribeiro FC; Junqueira JC; Dos Santos JD; de Barros PP; Rossoni RD; Shukla S; Fuchs BB; Shukla A; Mylonakis E
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253208
[TBL] [Abstract][Full Text] [Related]
14. Curative Treatment of Candidiasis by the Live Biotherapeutic Microorganism
Poupet C; Veisseire P; Bonnet M; Camarès O; Gachinat M; Dausset C; Chassard C; Nivoliez A; Bornes S
Microorganisms; 2019 Dec; 8(1):. PubMed ID: 31878039
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights.
Poupet C; Saraoui T; Veisseire P; Bonnet M; Dausset C; Gachinat M; Camarès O; Chassard C; Nivoliez A; Bornes S
PLoS One; 2019; 14(11):e0216184. PubMed ID: 31693670
[TBL] [Abstract][Full Text] [Related]
16. Comparative phase I randomized open-label pilot clinical trial of Gynophilus
Dausset C; Patrier S; Gajer P; Thoral C; Lenglet Y; Cardot JM; Judlin P; Ravel J; Nivoliez A
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1869-1880. PubMed ID: 30032443
[TBL] [Abstract][Full Text] [Related]
17. Technological and Probiotic Traits of the Lactobacilli Isolated From Vaginal Tract of the Healthy Women for Probiotic Use.
Bouridane H; Sifour M; Idoui T; Annick L; Thonard P
Iran J Biotechnol; 2016 Sep; 14(3):192-201. PubMed ID: 28959336
[TBL] [Abstract][Full Text] [Related]
18. Mucosal SIV Vaccines Comprising Inactivated Virus Particles and Bacterial Adjuvants Induce CD8(+) T-Regulatory Cells that Suppress SIV-Positive CD4(+) T-Cell Activation and Prevent SIV Infection in the Macaque Model.
Andrieu JM; Chen S; Lai C; Guo W; Lu W
Front Immunol; 2014; 5():297. PubMed ID: 25071760
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic approach to stability studies as a tool for the optimization and development of new products based on L. rhamnosus Lcr35® in compliance with current regulations.
Muller C; Busignies V; Mazel V; Forestier C; Nivoliez A; Tchoreloff P
PLoS One; 2013; 8(11):e79041. PubMed ID: 24244412
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
